Stroke Trials Registry

LMW heparin

Action
Low molecular weight heparin and heparinoids. See also specific compounds, including danaparoid, dalteparin, enoxaparin, nadroparin, tinzaparin.

Status

Trial(s)
= Ongoing
= Completed

CADISS Cervical Artery Dissection In Stroke Study: Feasibility Phase.

FISS Fraxiparin in Stroke Study

HAEST Heparin in Acute Embolic Stroke Trial

Low-molecular-weight Heparin for the Treatment of Acute Ischemic Stroke

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

TOPAS Therapy of Patients with Acute Stroke

Web Links and Publications

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke
55th American Academy of Neurology Meeting, 2003.

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke (Cochrane Review).
Cochrane Database Syst Rev. 2001;4:CD000119.

Low-molecular-weight heparins and heparinoids in acute ischemic stroke : a meta-analysis of randomized controlled trials.
Stroke 2000 Jul;31(7):1770-8

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Cochrane Database Systematic Review. 2000;2:CD000119.

Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial.
Lancet 2000 Apr 8;355(9211):1205-10

UID: 94